Showing results (91-100 of 107) with videos related to
Sort By:
Pageof 11
European Archives of Psychiatry and Clinical Neuroscience|March 24, 2012
Structural synaptic elements are differentially regulated in superior temporal cortex of schizophrenia patientsAndrea Schmitt, Fernando Leonardi-Essmann, Pascal F Durrenberger, et al.Journal of Clinical Psychology|January 19, 2022
Association of impulsivity with quality of life and well-being after alcohol withdrawal treatmentDaniela Reichl, Niklas Enewoldsen, Kiona K Weisel, et al.Substance Use & Misuse|February 10, 2022
Lower Emotion Regulation Competencies Mediate the Association between Impulsivity and Craving during Alcohol Withdrawal TreatmentDaniela Reichl, Niklas Enewoldsen, Kiona K Weisel, et al.Early Intervention in Psychiatry|March 27, 2015
Clinical high risk for psychosis: gender differences in symptoms and social functioningLiz Rietschel, Martin Lambert, Anne Karow, et al.Schizophrenia Research|July 10, 2024
Identifying differential predictors for treatment response to amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill patients with schizophrenia: Results of the COMBINE-studyViktoria Galuba, Joachim Cordes, Sandra Feyerabend, et al.Proceedings of the National Academy of Sciences of the United States of America|November 3, 2016
Dynamic brain network reconfiguration as a potential schizophrenia genetic risk mechanism modulated by NMDA receptor functionUrs Braun, Axel Schäfer, Danielle S Bassett, et al.Psychotherapy and Psychosomatics|May 25, 2025
Evaluation of a Smartphone App Intervention with Telephone Guidance as Transitional Support from Inpatient Treatment to Continuing Care for Individuals with Alcohol Use Disorder: Results from a Randomized Controlled TrialSebastian Saur, Kiona K Weisel, Catharina Lang, et al.Schizophrenia Bulletin|April 6, 2023
Prevention of First-Episode Psychosis in People at Clinical High Risk: A Randomized Controlled, Multicentre Trial Comparing Cognitive-Behavioral Therapy and Clinical Management Plus Low-Dose Aripiprazole or Placebo (PREVENT)Andreas Bechdolf, Hendrik Müller, Martin Hellmich, et al.The Lancet. Psychiatry|March 11, 2022
Amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill patients with schizophrenia in Germany (COMBINE): a double-blind randomised controlled trialChristian Schmidt-Kraepelin, Sandra Feyerabend, Christina Engelke, et al.European Archives of Psychiatry and Clinical Neuroscience|September 6, 2019
A randomized double-blind controlled trial to assess the benefits of amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill schizophrenia patients (COMBINE): methods and designChristian Schmidt-Kraepelin, Sandra Feyerabend, Christina Engelke, et al.Pageof 11